Your browser is no longer supported. Please, upgrade your browser.
Settings
NBRV Nabriva Therapeutics plc daily Stock Chart
NBRV [NASD]
Nabriva Therapeutics plc
Index- P/E- EPS (ttm)-2.10 Insider Own0.10% Shs Outstand74.37M Perf Week9.45%
Market Cap163.61M Forward P/E- EPS next Y-0.93 Insider Trans248.01% Shs Float72.13M Perf Month-7.95%
Income-121.70M PEG- EPS next Q-0.33 Inst Own51.80% Short Float2.32% Perf Quarter-30.60%
Sales3.80M P/S43.06 EPS this Y9.30% Inst Trans-7.63% Short Ratio1.34 Perf Half Y24.29%
Book/sh0.87 P/B2.53 EPS next Y22.50% ROA-117.60% Target Price8.07 Perf Year-49.54%
Cash/sh1.23 P/C1.79 EPS next 5Y- ROE-162.30% 52W Range1.12 - 4.40 Perf YTD50.68%
Dividend- P/FCF- EPS past 5Y-19.10% ROI-124.00% 52W High-50.00% Beta2.33
Dividend %- Quick Ratio5.60 Sales past 5Y- Gross Margin- 52W Low96.43% ATR0.16
Employees110 Current Ratio5.60 Sales Q/Q-77.60% Oper. Margin- RSI (14)46.55 Volatility6.38% 6.94%
OptionableYes Debt/Eq0.40 EPS Q/Q18.60% Profit Margin- Rel Volume1.35 Prev Close2.10
ShortableYes LT Debt/Eq0.40 EarningsJun 11 BMO Payout- Avg Volume1.24M Price2.20
Recom1.90 SMA20-0.09% SMA50-10.76% SMA200-4.32% Volume1,676,933 Change4.76%
May-02-19Upgrade Gabelli & Co Sell → Hold
May-02-19Reiterated H.C. Wainwright Buy $9 → $7
Sep-07-18Resumed Morgan Stanley Overweight
Mar-21-18Initiated BofA/Merrill Buy $10
Jan-17-18Initiated Morgan Stanley Overweight
Nov-01-17Reiterated H.C. Wainwright Buy $18 → $20
Aug-25-17Initiated SunTrust Buy $20
Feb-01-17Reiterated Wedbush Outperform $13
Oct-27-16Resumed Leerink Partners Outperform $14
Sep-08-16Initiated H.C. Wainwright Buy $16
Jan-27-16Initiated Gabelli & Co Buy $14
Nov-12-15Reiterated RBC Capital Mkts Outperform $21 → $22
Oct-13-15Initiated Wedbush Outperform
Oct-13-15Initiated RBC Capital Mkts Outperform $21
Oct-13-15Initiated Leerink Partners Outperform $19
Oct-12-15Initiated Needham Buy $15
Jun-19-19 10:37AM  KSHB, NBRV & EQBK- Class Action - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
07:00AM  Nabriva Therapeutics Submits Type A Meeting Request to FDA for Intravenous CONTEPO (fosfomycin) for injection GlobeNewswire
Jun-18-19 04:55PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nabriva Therapeutics plc of Class Action Lawsuit and Upcoming Deadline - NBRV ACCESSWIRE
04:55PM  IMPORTANT DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $50,000 to Contact the Firm ACCESSWIRE
09:47AM  Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Nabriva Therapeutics plc NBRV GlobeNewswire
Jun-17-19 07:51PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nabriva Therapeutics plc of Class Action Lawsuit and Upcoming Deadline - NBRV PR Newswire
10:36AM  KSHB, NBRV & EQBK- Bronstein, Gewirtz & Grossman, LLC Class Action Reminder ACCESSWIRE
09:57AM  INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Jun-16-19 09:23AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nabriva Therapeutics plc of Class Action Lawsuit and Upcoming Deadline - NBRV ACCESSWIRE
Jun-14-19 10:00PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Boston Scientific, KushCo, and Nabriva and Encourages Investors to Contact the Firm GlobeNewswire
06:20PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
03:00PM  KSHB, NBRV & EQBK - Bronstein, Gewirtz & Grossman, LLC Class Action Update GlobeNewswire
02:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nabriva Therapeutics plc of Class Action Lawsuit and Upcoming Deadline - NBRV ACCESSWIRE
10:09AM  KSHB, NBRV & EQBK- Bronstein, Gewirtz & Grossman, LLC Class Action Notification ACCESSWIRE
Jun-13-19 10:08AM  KSHB, NBRV & EQBK- Bronstein, Gewirtz & Grossman, LLC Class Action ACCESSWIRE
Jun-12-19 05:41PM  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nabriva Therapeutics plc of Class Action Lawsuit and Upcoming Deadline NBRV GlobeNewswire
Jun-11-19 07:55PM  SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE +9.38%
10:07AM  KSHB, NBRV & EQBK - Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
Jun-10-19 06:20PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nabriva Therapeutics plc of Class Action Lawsuit and Upcoming Deadline - NBRV ACCESSWIRE
02:25PM  INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Jun-08-19 08:05PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nabriva Therapeutics plc of Class Action Lawsuit and Upcoming Deadline - NBRV ACCESSWIRE
Jun-07-19 10:36AM  KSHB, NBRV & EQBK- Bronstein, Gewirtz & Grossman, LLC Class Action ACCESSWIRE -10.71%
10:00AM  KushCo Holdings, Inc. (KSHB), Nabriva Therapeutics PLC (NBRV), Equity Bancshares, Inc. (EQBK) -  Bronstein, Gewirtz & Grossman, LLC Class Action Reminder GlobeNewswire
09:27AM  Antimicrobials Working Group Commends Senator Isakson and Senator Casey for Introducing Legislation to Improve Access to Innovative Therapies to Fight Drug-Resistant Infections PR Newswire
Jun-05-19 10:00PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Boston Scientific, KushCo, and Nabriva and Encourages Investors to Contact the Firm GlobeNewswire
06:55PM  ROSEN, A TOP RANKED LAW FIRM, Reminds Nabriva Therapeutics plc Investors of Important Deadline in the Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm NBRV GlobeNewswire
06:52PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nabriva Therapeutics plc of Class Action Lawsuit and Upcoming Deadline NBRV GlobeNewswire
10:35AM  KSHB, NBRV & EQBK - Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
Jun-04-19 04:01PM  Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
11:20AM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Jun-03-19 06:15PM  NABRIVA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Nabriva Therapeutics plc To Contact The Firm ACCESSWIRE
06:00PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
03:19PM  Pawar Law Group Reminds Investors of Deadline in Securities Class Action Lawsuit Against Nabriva Therapeutics plc NBRV GlobeNewswire
10:35AM  KSHB, NBRV & EQBK - Bronstein, Gewirtz & Grossman, LLC Class Action Reminder ACCESSWIRE
Jun-01-19 03:27PM  LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors Who Suffered Large Investment Losses to Contact the Firm PR Newswire
10:15AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nabriva Therapeutics plc of Class Action Lawsuit and Upcoming Deadline - NBRV ACCESSWIRE
May-31-19 03:00PM  KushCo Holdings, Inc. (KSHB), Nabriva Therapeutics PLC (NBRV), Equity Bancshares, Inc. (EQBK) -  Bronstein, Gewirtz & Grossman, LLC Class Action GlobeNewswire
01:30PM  DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:34AM  KushCo Holdings, Inc. (KSHB), Nabriva Therapeutics PLC (NBRV), Equity Bancshares, Inc. (EQBK) - Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
May-30-19 05:35PM  Rosen, a Top Ranked Law Firm, Announces Filing of Securities Class Action Lawsuit Against Nabriva Therapeutics plc- NBRV PR Newswire
05:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nabriva Therapeutics plc of Class Action Lawsuit and Upcoming Deadline - NBRV ACCESSWIRE
03:20PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Nabriva Therapeutics plc To Contact The Firm ACCESSWIRE
12:43AM  NBRV NOTICE: Zhang Investor Law Announces a Securities Class Action Lawsuit Against Nabriva Therapeutics plc NBRV GlobeNewswire
May-29-19 10:33AM  KushCo Holdings, Inc. (KSHB), Nabriva Therapeutics PLC (NBRV), Equity Bancshares, Inc. (EQBK) - Bronstein, Gewirtz & Grossman, LLC Class Action Reminder ACCESSWIRE
May-28-19 08:30PM  SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE -5.04%
06:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nabriva Therapeutics plc of Class Action Lawsuit and Upcoming Deadline - NBRV ACCESSWIRE
05:44PM  Robbins Arroyo LLP: Nabriva Therapeutics plc (NBRV) Misled Shareholders According to a Recently Filed Lawsuit Business Wire
05:15PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Nabriva Therapeutics plc To Contact The Firm GlobeNewswire
10:32AM  KushCo Holdings, Inc. (KSHB), Nabriva Therapeutics PLC (NBRV), Equity Bancshares, Inc. (EQBK) - Bronstein, Gewirtz & Grossman, LLC Class Action Alert ACCESSWIRE
May-27-19 01:50PM  INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
May-26-19 09:51AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nabriva Therapeutics plc of Class Action Lawsuit and Upcoming Deadline - NBRV ACCESSWIRE
May-24-19 11:30PM  INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE +6.73%
08:55PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Nabriva Therapeutics plc To Contact The Firm ACCESSWIRE
03:05PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nabriva Therapeutics plc of Class Action Lawsuit and Upcoming Deadline - NBRV ACCESSWIRE
03:00PM  KushCo Holdings, Inc. (KSHB), Nabriva Therapeutics PLC (NBRV), Equity Bancshares, Inc. (EQBK) -  Bronstein, Gewirtz & Grossman, LLC Class Action GlobeNewswire
10:21AM  KushCo Holdings, Inc. (KSHB), Nabriva Therapeutics PLC (NBRV), Equity Bancshares, Inc. (EQBK) - Bronstein, Gewirtz & Grossman, LLC Class Action Reminder ACCESSWIRE
May-23-19 08:55PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE -5.51%
11:45AM  NABRIVA LAWSUIT FILED: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Nabriva Therapeutics plc; Encourages Investors with Losses in Excess of $100K to Contact the Firm NBRV GlobeNewswire
05:00AM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Boston Scientific, KushCo, and Nabriva and Encourages Investors to Contact the Firm GlobeNewswire
May-22-19 06:30PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
03:54PM  NBRV DEADLINE: Pawar Law Group Reminds Investors of Deadline in Securities Class Action Lawsuit Against Nabriva Therapeutics plc NBRV GlobeNewswire
03:14PM  Pomerantz Law Firm Announces the Filing of a Class Action against Nabriva Therapeutics plc and Certain Officers NBRV GlobeNewswire
10:20AM  KushCo Holdings, Inc. (KSHB), Nabriva Therapeutics PLC (NBRV), Equity Bancshares, Inc. (EQBK) - Bronstein, Gewirtz & Grossman, LLC Announces Class Action ACCESSWIRE
07:00AM  Nabriva Therapeutics to Present at the Jefferies 2019 Healthcare Conference GlobeNewswire
May-21-19 06:20PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
06:02PM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Nabriva Therapeutics plc Business Wire
04:27PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Nabriva Therapeutics plc To Contact The Firm GlobeNewswire
May-20-19 04:05PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Nabriva Therapeutics plc To Contact The Firm ACCESSWIRE -7.36%
02:50PM  INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
02:17PM  INVESTOR DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:19AM  KushCo Holdings, Inc. (KSHB), Nabriva Therapeutics PLC (NBRV), Equity Bancshares, Inc. (EQBK) - Bronstein, Gewirtz & Grossman, LLC Class Action ACCESSWIRE
May-17-19 08:20PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:27AM  NBRV ALERT: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Nabriva Therapeutics plc NBRV GlobeNewswire
05:00AM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Boston Scientific, KushCo, and Nabriva and Encourages Investors to Contact the Firm GlobeNewswire
May-16-19 07:39PM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Nabriva Therapeutics plc Business Wire
01:40PM  IMPORTANT DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:34AM  Nabriva Therapeutics PLC (NBRV) Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action and Lead Plaintiff Deadline: July 8, 2019 ACCESSWIRE
May-15-19 06:27PM  NBRVALERT: Zhang Investor Law Announces the Filing of a Securities Class Action Lawsuit Against Nabriva Therapeutics plc NBRV GlobeNewswire
12:35PM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
May-14-19 05:30PM  NABRIVA DEADLINE ALERT: Rosen Law Firm Reminds Nabriva Therapeutics plc Investors of Important Deadline in the Securities Class Action NBRV Business Wire
05:01PM  NABRIVA THERAPEUTICS PLC ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Nabriva Therapeutics plc GlobeNewswire
04:09PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Nabriva Therapeutics plc Investors (NBRV) Business Wire
03:00PM  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:45PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Nabriva Therapeutics plc To Contact The Firm ACCESSWIRE
11:20AM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
10:33AM  Nabriva Therapeutics PLC (NBRV) Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline: July 8, 2019 ACCESSWIRE
May-13-19 05:21PM  Lifshitz & Miller LLP Announces Investigation of Glencore plc, Kingstone Companies, Inc., Mallinckrodt PLC, Metro Bank PLC, Momo Inc., Nabriva Therapeutics PLC, National General Holdings Corp, and Zillow Group, Inc. PR Newswire
04:17PM  IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
12:25PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Nabriva Therapeutics plc To Contact The Firm GlobeNewswire
May-10-19 03:45PM  SHAREHOLDER INVESTIGATION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE +9.88%
03:00PM  SHAREHOLDER ALERT - Nabriva Therapeutics PLC (NBRV) Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline: July 8, 2019 GlobeNewswire
01:50PM  NABRIVA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Nabriva Therapeutics plc To Contact The Firm ACCESSWIRE
12:01PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
11:00AM  SHAREHOLDER ALERT - Nabriva Therapeutics PLC (NBRV) Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline: July 8, 2019 ACCESSWIRE
May-09-19 09:00PM  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Nabriva Therapeutics plc (NASDAQ: NBRV) and Encourages Nabriva Investors to Contact the Firm GlobeNewswire +5.65%
05:24PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Nabriva Therapeutics plc NBRV Business Wire
05:20PM  NABRIVA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Nabriva Therapeutics plc To Contact The Firm ACCESSWIRE
12:55PM  Glancy Prongay & Murray LLP Files a Securities Class Action Behalf of Nabriva Therapeutics plc Investors (NBRV) Business Wire
May-08-19 04:01PM  Nabriva Therapeutics to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference GlobeNewswire +5.50%
02:29PM  How Many Nabriva Therapeutics plc (NASDAQ:NBRV) Shares Do Institutions Own? Simply Wall St.
Nabriva Therapeutics plc, a biopharmaceutical company, engages in the research and development of anti-infective agents to treat infections in humans. Its lead product candidate is lefamulin, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneumonia; and has completed Phase II clinical trials for the treatment of acute bacterial skin and skin structure infection. The company is also developing CONTEPO, an epoxide antibiotic for use in treating complicated urinary tract infections. In addition, it is developing lefamulin for use in the treatment of ventilator-associated bacterial pneumonia or hospital-acquired bacterial pneumonia and sexually transmitted infections, as well as Pediatric oral formulation. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics plc in 2007. Nabriva Therapeutics plc was incorporated in 2005 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rowland Charles A JrDirectorDec 24Buy1.3153,00069,43053,000Dec 27 04:05 PM
Talbot George HarrisonDirectorJul 31Buy2.7514,50039,87547,640Aug 02 05:52 PM
BURGESS DANIEL DDirectorJul 31Buy2.7536,00099,00036,000Aug 02 05:51 PM
Gelone Steven P.Chief Scientific OfficerJun 23Buy3.8210,00038,20022,740Jun 26 09:09 AM
Broom Colin MDCEO & DirectorJun 22Buy3.725,00018,600102,151Jun 25 09:47 AM
Schranz JenniferChief Medical OfficerJun 22Buy3.735,50020,5155,500Jun 25 09:47 AM